You have accessJournal of UrologyCME1 Apr 2023MP70-08 OUTCOMES AND SAFETY OF ROBOTIC-ASSISTED LAPAROSCOPIC URETERAL REIMPLANTATION IN INFANTS LESS THAN 24 MONTHS OF AGE WITH PRIMARY VESICOURETERAL REFLUX Sahar Eftekharzadeh, Katherine Fischer, Aznive Aghababian, Sameer Mittal, John Weaver, Karl Godlewski, Christopher Long, Dana Weiss, Aseem Shukla, and Arun Srinivasan Sahar EftekharzadehSahar Eftekharzadeh More articles by this author , Katherine FischerKatherine Fischer More articles by this author , Aznive AghababianAznive Aghababian More articles by this author , Sameer MittalSameer Mittal More articles by this author , John WeaverJohn Weaver More articles by this author , Karl GodlewskiKarl Godlewski More articles by this author , Christopher LongChristopher Long More articles by this author , Dana WeissDana Weiss More articles by this author , Aseem ShuklaAseem Shukla More articles by this author , and Arun SrinivasanArun Srinivasan More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003338.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: While the use of robotic assisted laparoscopic ureteral reimplantation (RALUR) for management of vesicoureteral reflux (VUR) in the pediatric population has been well reported over the years, the use of RALUR in the infant cohort (<24 months of age) remains lower than older children likely due to perceived technical challenges including robotic arm collision in a small working space. We hypothesize that the safety and efficacy of performing RALUR on patients <24 months of age is comparable to an older cohort. METHODS: An IRB approved single-institutional registry was queried to retrospectively identify all patients under 18 years of age who underwent RALUR for primary VUR between 2012 - 2019. Patients undergoing concomitant procedures or with duplex renal collecting systems were excluded. We categorized patients into two groups: 1) <24 months of age 2). >24 months of age. Demographics, pre-operative imaging, operative details, and post-operative outcomes including 30-day complications, persistent VUR, incidence of febrile UTI (fUTI), dysfunctional voiding, and rate of reintervention was aggregated. RESULTS: Of 172 patients who underwent RALUR during the study period, 141 (82%) met inclusion criteria: 29 in the <24 months group, and 112 in the >24 months group (Table 1). There was a higher incidence of breakthrough UTIs in the <24 months group (p<0.001), occurring in 28/29 patients (97%) in this group. Patients <24 months old had a higher percentage of fUTIs within 30 days of surgery (Clavien-Dindo Grade II). There was no statistical difference in the length of surgery, use of straight catheterization, persistent VUR, dysfunctional voiding, fUTIs occurring >30 days after surgery, or need for further interventions between the two groups (Table 2). 7 patients from both groups required subsequent intervention. CONCLUSIONS: Outcomes of patients undergoing RALUR for primary VUR are favorable regardless of age. RALUR is technically feasible, safe, and efficacious for management of primary VUR in patients younger than 24 months. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1006 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sahar Eftekharzadeh More articles by this author Katherine Fischer More articles by this author Aznive Aghababian More articles by this author Sameer Mittal More articles by this author John Weaver More articles by this author Karl Godlewski More articles by this author Christopher Long More articles by this author Dana Weiss More articles by this author Aseem Shukla More articles by this author Arun Srinivasan More articles by this author Expand All Advertisement PDF downloadLoading ...